Novanta (NOVT) Gets a Hold from Robert W. Baird
TipRanks (Mon, 26-Jan 8:36 AM ET)
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026
Business Wire (Thu, 22-Jan 11:00 AM ET)
Business Wire (Thu, 18-Dec 11:00 AM ET)
Business Wire (Mon, 15-Dec 11:00 AM ET)
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
Business Wire (Fri, 7-Nov 7:15 AM ET)
Novanta Inc. Announces Offering of Tangible Equity Units
Business Wire (Wed, 5-Nov 4:12 PM ET)
Novanta Announces Financial Results for the Third Quarter 2025
Business Wire (Mon, 3-Nov 5:00 PM ET)
Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
Business Wire (Tue, 28-Oct 11:00 AM ET)
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Novanta - Common Shares trades on the NASDAQ stock market under the symbol NOVT.
As of January 26, 2026, NOVT stock price declined to $137.48 with 43,735 million shares trading.
NOVT has a beta of 1.86, meaning it tends to be more sensitive to market movements. NOVT has a correlation of 0.41 to the broad based SPY ETF.
NOVT has a market cap of $4.94 billion. This is considered a Mid Cap stock.
Last quarter Novanta - Common Shares reported $248 million in Revenue and $.87 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.06.
In the last 3 years, NOVT traded as high as $187.61 and as low as $98.27.
The top ETF exchange traded funds that NOVT belongs to (by Net Assets): IJH, VTI, IWM, VGT, VB.
NOVT has underperformed the market in the last year with a return of -8.1%, while SPY returned +14.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NOVT shares. However, NOVT has outperformed the market in the last 3 month and 2 week periods, returning +15.7% and +5.0%, while SPY returned +3.5% and -0.1%, respectively. This indicates NOVT has been having a stronger performance recently.
NOVT support price is $133.54 and resistance is $142.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVT shares will trade within this expected range on the day.